Phakic Intraocular Lenses

Chang, Grace C; Pineda, Roberto

doi:10.1097/iio.0b013e3181c55227

Cited by 3 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although PIOL implantation for myopia correction in adults proved to be safe and effective, 1,9,12 performing surgery in pediatric patients may be somewhat controversial. People are concerned that PIOL implantation in children may cause complications such as acute or chronic inflammation, glaucoma, cataract, or a Abbreviations: ACD, anterior chamber depth; AL, axis length; BCVA, best corrected visual acuity in LogMAR; CED, corneal endotheliam density (cells/mm 2 ); PIOL, phakic intraocular lens; SE, spherical equivalent power; UCVA, uncorrected visual acuity in LogMAR.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Posterior sclera reinforcement and phakic intraocular lens implantation for highly myopic amblyopia in children: a 3-year follow-up

Zhu

et al. 2014

Eye

View full text Add to dashboard Cite

Purpose To study the safety and efficacy of posterior scleral reinforcement (PSR) combined with phakic intraocular lens (PIOLs) implantation for highly myopic amblyopia in children. Methods This study included eight highly myopic children (11 eyes) who failed in conventional therapy for amblyopia using various combination of spectacles, contact lenses, and intensive patching before enrollment into this study. They were treated sequentially with PSR and PIOL implantation, and were followed up for 3 years after surgery. Uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA) in LogMAR, spherical equivalent power (SE), and complications were evaluated. Results Before surgery, the mean UCVA was 1.59 ± 0.33, BCVA, 0.74 ± 0.37, SE, À 17.57 ± 5.56D, the axial length (AL), 30.09±2.18 mm. After PSR, BCVA improved one line in three patients, the rest were unchanged, and AL was unchanged among all cases. Six eyes of three patients were implanted with an iris-claw PIOL and five eyes of five patients were implanted with a posterior PIOL. After completion of treatment, the mean UCVA was 0.44 ± 0.21, BCVA 0.38±0.24, SE À 0.54±0.74 D, and AL 30.35±2.29 mm. No patient experienced complications. Conclusion Combined PSR and PIOL implantation treatment for highly myopic amblyopia in children is safe and effective.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Corneal refractive surgery is limited to patients with myopia of 10 D or less owing to the concern of ectasia secondary to a reduction in the residual stromal bed. 1,2 Reinforcement of the posterior sclera can control the progression of myopia. Phakic intraocular lens (PIOLs) implantation for children has been reported in the literature.…”

Section: Introductionmentioning

confidence: 99%

Posterior sclera reinforcement and phakic intraocular lens implantation for highly myopic amblyopia in children: a 3-year follow-up

Zhu

et al. 2014

Eye

View full text Add to dashboard Cite

show abstract

Types of intraocular lenses for cataract surgery in eyes with uveitis

Leung

Lindsley

Kuo

2014

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Background Cataract formation often occurs in people with uveitis. It is unclear which intraocular lens (IOL) type is optimal for use in cataract surgery for eyes with uveitis. Objectives To summarize the effects of different IOLs on visual acuity, other visual outcomes, and quality of life in people with uveitis. Search methods We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2013, Issue 7), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to August 2013), EMBASE (January 1980 to August 2013), Latin American and Caribbean Literature on Health Sciences (LILACS) (January 1982 to August 2013), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com), ClinicalTrials.gov (www.clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 14 August 2013. We also performed forward and backward searching using the Science Citation Index and the reference lists of the included studies, respectively, in August 2013. Selection criteria We included randomized controlled trials (RCTs) comparing hydrophobic or hydrophilic acrylic, silicone, or poly(methyl methacrylate) (PMMA) IOLs with or without heparin-surface modification (HSM), with each other, or with no treatment in adults with uveitis, for any indication, undergoing cataract surgery. Data collection and analysis We used standard methodological procedures expected by The Cochrane Collaboration. Two review authors screened the search results and for included studies, assessed the risk of bias and extracted data independently. We contacted study investigators for additional information. We did not perform a meta-analysis due to variability in reporting and follow-up intervals for the primary and secondary outcomes of interest. Main results We included four RCTs involving 216 participants (range of 2 to 140 participants with uveitic cataract per trial) and comparing up to four types of IOLs. The largest study was an international study with centers in Brazil, Egypt, Finland, France, Japan, the Netherlands, Slovak Republic, Spain, and the USA; two studies were conducted in Germany and one in Saudi Arabia. There was substantial heterogeneity with respect to the ages of participants and etiologies of uveitis within and across studies. The length of follow-up among the studies ranged from 1 to 24 months after cataract surgery. The studies were at low risk of selection bias, but two of the four studies did not employ masking and only one study included all randomized participants in the final analyses. The funding source was disclosed by investigators of the largest study (professional society) and not reported by the other three. Due to heterogeneity in lens types evaluated and outcomes reported among the trials, we did not combine d...

show abstract

Phakic Intraocular Lens Implantation in Keratoconus

Krakauer

Lifshitz

2018

Controversies in the Management of Keratoconus

View full text Add to dashboard Cite

Phakic Intraocular Lenses

Cited by 3 publications

References 30 publications

Posterior sclera reinforcement and phakic intraocular lens implantation for highly myopic amblyopia in children: a 3-year follow-up

Posterior sclera reinforcement and phakic intraocular lens implantation for highly myopic amblyopia in children: a 3-year follow-up

Types of intraocular lenses for cataract surgery in eyes with uveitis

Phakic Intraocular Lens Implantation in Keratoconus

Contact Info

Product

Resources

About